(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…
Stress laid on proper hygiene to prevent shigella spread in Kerala
A total of 15 cases, including one death, have been reported across the State this month due to shigellosis, a...






